D. Bedognetti

发表

Steven J. M. Jones, James A. Eddy, David L. Gibbs, 2018, Immunity.

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.

Jérôme Galon, Davide Bedognetti, Francesco M Marincola, 2013, Immunity.

A collection of annotated and harmonized human breast cancer transcriptome datasets, including immunologic classification

Sabri Boughorbel, Michele Ceccarelli, Scott R. Presnell, 2017, F1000Research.

Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus

F. Marincola, D. Bedognetti, K. Matsuura, 2015, Journal of Translational Medicine.

Molecular impact of graphene oxide with different shape dimension on human immune cells

D. Bedognetti, M. Pescatori, A. Bianco, 2015, Journal of Immunotherapy for Cancer.

Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response

L. D. Miller, F. Marincola, F. Bertucci, 2020, Journal for ImmunoTherapy of Cancer.

Impact of carbon nanotubes and graphene on immune cells

Marco Orecchioni, Lucia Gemma Delogu, Alberto Bianco, 2014, Journal of Translational Medicine.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discovery

F. Marincola, B. Fox, L. Butterfield, 2011, Journal of Translational Medicine.

Toward High-Dimensional Single-Cell Analysis of Graphene Oxide Biological Impact: Tracking on Immune Cells by Single-Cell Mass Cytometry.

G. Cesareni, D. Bedognetti, C. Fuoco, 2020, Small.

Cancer Immunotherapy Principles and Practice

Ke Liu, Pedro Romero, Patricia A. Young, 2018 .

STXBP6, reciprocally regulated with autophagy, reduces triple negative breast cancer aggressiveness

Najeeb M. Halabi, Noor Al Khori, K. Suhre, 2020, Clinical and Translational Medicine.

Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic

Matteo Pasquali, Yury Gogotsi, Flavia Vitale, 2020, ACS nano.

Conservation of immune gene signatures in solid tumors and prognostic implications

L. Miller, D. Bedognetti, J. Chou, 2016, BMC Cancer.

F. Marincola, P. Ascierto, D. Bedognetti, 2014, Molecular oncology.

F. Marincola, P. Ascierto, D. Bedognetti, 2014, Journal of Translational Medicine.

Functionalized multiwalled carbon nanotubes as ultrasound contrast agents

Paola Nicolussi, Lucia Gemma Delogu, Alberto Bianco, 2012, Proceedings of the National Academy of Sciences.

Melanoma NOS1 expression promotes dysfunctional IFN signaling.

F. Marincola, G. Weiss, S. Rosenberg, 2014, The Journal of clinical investigation.

Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients

F. Marincola, D. Bedognetti, M. Maio, 2017, Oncoimmunology.

Impaired Response to Influenza Vaccine Associated with Persistent Memory B Cell Depletion in Non-Hodgkin’s Lymphoma Patients Treated with Rituximab-Containing Regimens

F. Marincola, D. Bedognetti, M. Ferrarini, 2011, The Journal of Immunology.

The immune landscape of solid pediatric tumors

V. Thorsson, Borbala Mifsud, D. Bedognetti, 2022, Journal of experimental & clinical cancer research : CR.

Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK- and NKT cells, and clinical outcome.

R. Tollenaar, P. Kuppen, D. Bedognetti, 2020, Molecular immunology.

Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population

F. Marincola, D. Bedognetti, S. Adams, 2012, Medical Oncology.

Integrated transcriptional‐phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients

D. Chaussabel, D. Bedognetti, L. De Cecco, 2021, Clinical and translational medicine.

HLA-G: A New Immune Checkpoint in Cancer?

P. Kuppen, D. Bedognetti, W. Hendrickx, 2020, International journal of molecular sciences.

Common pathways to tumor rejection

F. Marincola, D. Bedognetti, E. Wang, 2013, Annals of the New York Academy of Sciences.

Bevacizumab plus Fotemustine as First-line Treatment in Metastatic Melanoma Patients: Clinical Activity and Modulation of Angiogenesis and Lymphangiogenesis Factors

D. Bedognetti, P. Queirolo, M. Del Vecchio, 2010, Clinical Cancer Research.

A Neutrophil-Driven Inflammatory Signature Characterizes the Blood Transcriptome Fingerprint of Psoriasis

D. Chaussabel, D. Bedognetti, T. Kino, 2020, Frontiers in Immunology.

Definition of erythroid cell‐positive blood transcriptome phenotypes associated with severe respiratory syncytial virus infection

Matthew C. Altman, O. Ramilo, A. Mejias, 2020, Clinical and translational medicine.

Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets

P. Danaher, D. Bedognetti, J. Beechem, 2020, Nature Cancer.

The abundance of Nudix hydrolase 16 transcripts is elevated in human sepsis: perspectives gained during a hands-on reductionist investigation workshop

D. Chaussabel, S. Boughorbel, D. Bedognetti, 2018, bioRxiv.

Direct T cell–tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme

F. Marincola, D. Bedognetti, M. Sabatino, 2014, British Journal of Cancer.

Annexin A3 in sepsis: novel perspectives from an exploration of public transcriptome data

D. Chaussabel, D. Bedognetti, D. Rinchai, 2020, Immunology.

Elevation of FAM129A in neutrophils exposed to serum of patients with severe sepsis: in silico investigations during a hands on training workshop and follow on validation of protein expression in neutrophils

J. Banchereau, D. Chaussabel, D. Bedognetti, 2019, bioRxiv.

Intratumoral Gene Signatures and Host Genetic Variations Associated With Immune Responsiveness

F. Marincola, D. Bedognetti, E. Wang, 2021, Cancer Immunotherapy Principles and Practice.

The Immune Landscape of Cancer.

James A. Eddy, David L. Gibbs, Evan O. Paull, 2019, Immunity.

Loss of ribonuclease DIS3 hampers genome integrity in myeloma by disrupting DNA:RNA hybrid metabolism

G. Parmigiani, G. Tonon, D. Bedognetti, 2022, The EMBO journal.

Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells.

A. Ballestrero, F. Patrone, S. Parodi, 2010, Experimental hematology.

Immune Profiling and Multiplexed Label‐Free Detection of 2D MXenes by Mass Cytometry and High‐Dimensional Imaging

K. Ley, Y. Gogotsi, D. Bedognetti, 2022, Advanced materials.

Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68

F. Marincola, P. Ascierto, D. Bedognetti, 2011, BMC Cancer.

Correlation of Immunological and Histopathological Features with Gene Expression-Based Classifiers in Colon Cancer Patients

P. Kuppen, D. Bedognetti, W. Mesker, 2022, International journal of molecular sciences.

Raghvendra Mall, S. Bedri, D. Bedognetti, 2022, Journal of Translational Medicine.

High–temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines

D. Chaussabel, A. Ballestrero, D. Bedognetti, 2022, Science advances.

Analytic pipelines to assess the relationship between immune response and germline genetics in human tumors

Rosalyn W. Sayaman, V. Thorsson, E. Ziv, 2022, STAR protocols.

Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients

F. Marincola, P. Ascierto, H. Khalak, 2013, Journal of Translational Medicine.

Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

F. Marincola, B. Seliger, D. Bedognetti, 2016, Journal of Translational Medicine.

Meta-analysis and metagenes

F. Marincola, D. Bedognetti, E. Wang, 2014, Oncoimmunology.

Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer

Y. Pommier, A. Ballestrero, D. Bedognetti, 2017, Journal of Translational Medicine.

Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer

V. Torri, Raghvendra Mall, G. Apolone, 2021, Cancer discovery.

CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2

R. Simon, F. Marincola, S. Rosenberg, 2013, British Journal of Cancer.

A Community Challenge to Predict Clinical Outcomes After Immune Checkpoint Blockade in Non-Small Cell Lung Cancer

J. Szustakowski, T. Laajala, Raghvendra Mall, 2022, bioRxiv.

How can nanotechnology help the fight against breast cancer?

Gianni Ciofani, Lucia Gemma Delogu, Alberto Bianco, 2018, Nanoscale.

2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2

E. Demir, Y. Gogotsi, D. Bedognetti, 2021, Nano Today.

Single‐Cell Analysis: Toward High‐Dimensional Single‐Cell Analysis of Graphene Oxide Biological Impact: Tracking on Immune Cells by Single‐Cell Mass Cytometry (Small 21/2020)

G. Cesareni, D. Bedognetti, C. Fuoco, 2020, Small.

Impact of the surface functionalization on nanodiamond biocompatibility: a comprehensive view on human blood immune cells

Marco Orecchioni, Akcan Istif, Lucia Gemma Delogu, 2020 .

Graphene and other 2D materials: a multidisciplinary analysis to uncover the hidden potential as cancer theranostics

Bengt Fadeel, Flavia Vitale, Cinzia Casiraghi, 2020, Theranostics.

Photodynamic Therapy Based on Graphene and MXene in Cancer Theranostics

Flavia Vitale, Arianna Gazzi, Lucia Gemma Delogu, 2019, Front. Bioeng. Biotechnol..

Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells

Gianni Cesareni, Marco Orecchioni, Kostas Kostarelos, 2017, Nature Communications.

Functionalized carbon nanotubes as immunomodulator systems.

Lucia Gemma Delogu, Alberto Bianco, Cécilia Ménard-Moyon, 2013, Biomaterials.

BACH2 represses effector programmes to stabilize Treg-mediated immune homeostasis - a new target in tumor immunotherapy?

F. Marincola, D. Bedognetti, B. Dema, 2013, Journal of Immunotherapy for Cancer.

Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications

Rosalyn W. Sayaman, E. Ziv, D. Bedognetti, 2019, Front. Oncol..

An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients.

M. Gallucci, D. Bedognetti, F. Boccardo, 2010, European urology.

Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity

D. Bedognetti, S. Uddin, D. Rinchai, 2021, Journal of experimental & clinical cancer research : CR.

Germline genetic contribution to the immune landscape of cancer

Rosalyn W. Sayaman, V. Thorsson, F. Marincola, 2020, bioRxiv.

A map of tumor–host interactions in glioma at single-cell resolution

F. Tang, M. Ceccarelli, L. Cerulo, 2020, GigaScience.

Insights Into the Role of CircRNAs: Biogenesis, Characterization, Functional, and Clinical Impact in Human Malignancies

Ikhlak Ahmed, D. Bedognetti, R. Reddy, 2021, Frontiers in Cell and Developmental Biology.

Disentangling the relationship between tumor genetic programs and immune responsiveness.

M. Ceccarelli, L. Miller, B. Seliger, 2016, Current opinion in immunology.

Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer

A. Ballestrero, D. Bedognetti, Sylvain Brohée, 2019, Breast Cancer Research and Treatment.

Monoallelic expression in melanoma

Hakeem G. Almabrazi, F. Marincola, B. Seliger, 2019, Journal of Translational Medicine.

Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and correlation with integrated, multiomic analysis in the NIBIT-M4 trial

T. Noviello, C. Sautès-Fridman, G. Pruneri, 2023, medRxiv.

Correction: A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival

T. Hudson, F. Marincola, M. Ceccarelli, 2020, British Journal of Cancer.

A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival

T. Hudson, F. Marincola, M. Ceccarelli, 2020, British Journal of Cancer.

A MAP of tumor-host interactions in glioma at single cell resolution

F. Tang, M. Ceccarelli, L. Cerulo, 2019, bioRxiv.

Tumor mutational burden is a determinant of immune-mediated survival in breast cancer

Guangxu Jin, Michael L. Gatza, Charles M Perou, 2018, Oncoimmunology.

Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis

F. Marincola, F. Bertucci, M. Ceccarelli, 2017, Oncoimmunology.

Pazopanib induces dramatic but transient contraction of myeloid suppression compartment in favor of adaptive immunity

D. Chaussabel, D. Bedognetti, L. De Cecco, 2020, bioRxiv.

Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness

F. Marincola, C. Print, L. Miller, 2016, Cancer Immunology Research.

The Immune landscape of pediatric solid tumors

D. Bedognetti, W. Mifsud, W. Hendrickx, 2021, bioRxiv.

The Biology of Immune-Active Cancers and Their Regulatory Mechanisms.

F. Marincola, D. Bedognetti, E. Wang, 2020, Cancer treatment and research.

Harnessing the immune system for the treatment of melanoma: current status and future prospects

F. Marincola, B. Seliger, D. Bedognetti, 2016, Expert review of clinical immunology.

Checkpoint Inhibitors and Their Application in Breast Cancer

F. Marincola, B. Seliger, D. Bedognetti, 2016, Breast Care.

Prognostic and predictive immune gene signatures in breast cancer

Davide Bedognetti, Francesco M Marincola, F. Marincola, 2015, Current opinion in oncology.

Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy

D. Bedognetti, R. Reddy, M. Haris, 2021, Molecular cancer.

Evolution of Metastases in Space and Time under Immune Selection

F. Marincola, M. Ceccarelli, J. Galon, 2018, Cell.

Correction: Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy

S. Batra, D. Bedognetti, M. Haris, 2021, Signal Transduction and Targeted Therapy.

Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy

S. Batra, D. Bedognetti, M. Haris, 2021, Signal Transduction and Targeted Therapy.

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

Joseph F. Murphy, V. Thorsson, F. Marincola, 2019, Journal of Immunotherapy for Cancer.

Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma

F. Marincola, D. Bedognetti, E. Wang, 2014, Expert opinion on biological therapy.

The stable traits of melanoma genetics: an alternate approach to target discovery

F. Marincola, D. Bedognetti, E. Wang, 2012, BMC Genomics.

An immunologic portrait of cancer

F. Marincola, D. Bedognetti, E. Wang, 2011, Journal of Translational Medicine.

Network-based identification of key master regulators associated with an immune-silent cancer phenotype

M. Ceccarelli, Raghvendra Mall, D. Bedognetti, 2021, Briefings Bioinform..

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer

F. Marincola, F. Bertucci, D. Birnbaum, 2018, British Journal of Cancer.

Immune oncology, immune responsiveness and the theory of everything

T. Hudson, F. Marincola, L. Butterfield, 2018, Journal of Immunotherapy for Cancer.

Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk

F. Marincola, G. Coukos, D. Bedognetti, 2016, Oncoimmunology.

F. Marincola, P. Ascierto, D. Bedognetti, 2014, Journal of Translational Medicine.

Toward the Identification of Genetic Determinants of Responsiveness to Cancer Immunotherapy

F. Marincola, D. Bedognetti, E. Wang, 2015 .

IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes

F. Marincola, D. Bedognetti, E. Wang, 2013, British Journal of Cancer.

Molecular Profiling of Immunotherapeutic Resistance

F. Marincola, D. Bedognetti, E. Wang, 2013 .

IRF5 gene polymorphisms in melanoma

F. Marincola, R. Simon, S. Rosenberg, 2012, Journal of Translational Medicine.

The stable traits of melanoma genetics: an alternate approach to target discovery

F. Marincola, D. Bedognetti, E. Wang, 2012, BMC Genomics.

Functional Genome Profiling to Understand Cancer Immune Responsiveness.

F. Marincola, D. Bedognetti, E. Wang, 2020, Methods in molecular biology.

miRNAs as novel immunoregulators in cancer.

D. Bedognetti, R. Reddy, M. Haris, 2021, Seminars in cell & developmental biology.

Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications

F. Marincola, P. Kuppen, D. Bedognetti, 2017, International journal of molecular sciences.

Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients

F. Marincola, P. Ascierto, H. Khalak, 2013, Journal of Translational Medicine.

Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature

J. Blay, F. Bertucci, D. Birnbaum, 2022, Journal for ImmunoTherapy of Cancer.

Graphene, other carbon nanomaterials and the immune system: toward nanoimmunity-by-design

Bengt Fadeel, Gianaurelio Cuniberti, Alberto Bianco, 2020, Journal of Physics: Materials.

Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome data

Scott R. Presnell, Matthew C. Altman, V. Pascual, 2021, Nature Communications.

A modular framework for the development of targeted Covid-19 blood transcript profiling panels

Darawan Rinchai, Matthew Altman, Mohammed Toufiq, 2020, Journal of Translational Medicine.

A Novel Repertoire of Blood Transcriptome Modules Based on Co-expression Patterns

Virginia Pascual, Matthew, Scott R. Presnell, 2019 .

Genomic landscape of tumor-host interactions with differential prognostic and predictive connotations

F. Marincola, F. Bertucci, M. Ceccarelli, 2019, bioRxiv.

Genomic landscape of tumor-host interactions with differential prognostic and predictive connotations

F. Marincola, F. Bertucci, M. Ceccarelli, 2019, bioRxiv.

Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes

C. Print, L. Miller, C. Langefeld, 2021, Frontiers in Oncology.

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives

D. Bedognetti, Ghaneya Al-Khadairi, J. Decock, 2018, Front. Immunol..

Transcriptomic profile investigations highlight a putative role for NUDT16 in sepsis

D. Chaussabel, S. Boughorbel, D. Bedognetti, 2022, Journal of cellular and molecular medicine.

BloodGen3Module: blood transcriptional module repertoire analysis and visualization using R

Darawan Rinchai, Davide Bedognetti, Damien Chaussabel, 2020, bioRxiv.

Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.

D. Bedognetti, P. Bruzzi, P. Queirolo, 2011, Journal of the National Cancer Institute.

Sterol synthesis pathway inhibition as a target for cancer treatment.

A. Ballestrero, D. Bedognetti, G. Zoppoli, 2020, Cancer letters.

Long-Chain Acyl-CoA Synthetase 1 Role in Sepsis and Immunity: Perspectives From a Parallel Review of Public Transcriptome Datasets and of the Literature

Sabri Boughorbel, Darawan Rinchai, Damien Chaussabel, 2019, Front. Immunol..

Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment

Yingdong Zhao, Davide Bedognetti, Francesco M Marincola, 2011, BMC Medical Genomics.

Gene-expression profiling in vaccine therapy and immunotherapy for cancer

F. Marincola, D. Bedognetti, E. Wang, 2010, Expert review of vaccines.

The MAPK hypothesis: immune-regulatory effects of MAPK-pathway genetic dysregulations and implications for breast cancer immunotherapy

D. Bedognetti, E. Wang, J. Decock, 2017, Emerging topics in life sciences.

Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod

F. Marincola, A. Heguy, S. Demaria, 2019, Scientific Reports.

Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments

Tariq Ahmad Masoodi, S. Batra, D. Bedognetti, 2022, Molecular Cancer.

Potent natural killer (NK) and myeloid blood cell remodeling by cabozantinib (Cabo) in pre-treated metastatic renal cell carcinoma (mRCC) patients (pts).

D. Bedognetti, D. Rinchai, G. Procopio, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Molecular and Genomic Impact of Large and Small Lateral Dimension Graphene Oxide Sheets on Human Immune Cells from Healthy Donors

Marco Orecchioni, Kostas Kostarelos, Lucia Gemma Delogu, 2016, Advanced healthcare materials.

Development and Characterization of a Fixed Repertoire of Blood Transcriptome Modules Based on Co-expression Patterns Across Immunological States

Fleur Mougin, Virginia Pascual, Patricia Thébault, 2019, bioRxiv.

Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis

F. Marincola, D. Bedognetti, E. Wang, 2011, Journal of Translational Medicine.

Prediction of response to anticancer immunotherapy using gene signatures.

F. Marincola, D. Bedognetti, E. Wang, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer

A. Ballestrero, O. Delpuech, D. Bedognetti, 2021, JCI insight.

The role of germline genetics in shaping the tumor immune landscape is largely unknown. Using genotypes from >9,000

Denise, Wolf, Rosalyn W. Sayaman, 2020 .

Interferon-γ and Tumor Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype

F. Marincola, D. Bedognetti, E. Wang, 2016, Scientific Reports.

Toward the identification of genetic determinants of breast cancer immune responsiveness

F. Marincola, M. Ceccarelli, H. Bensmail, 2015, Journal of Immunotherapy for Cancer.

The sialyl-glycolipid SSEA 4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features

F. Marincola, C. Hudis, M. Ceccarelli, 2015 .

The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28–Costimulated T Cells Prepared for Adoptive Therapy

F. Marincola, G. Coukos, D. Powell, 2015, Clinical Cancer Research.

A Multi-layer Molecular Fresco of the Immune Diversity across Hematologic Malignancies.

D. Bedognetti, 2020, Cancer cell.

Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data

D. Bedognetti, F. Minuto, G. Zoppoli, 2012, Pituitary.

High temporal resolution systems profiling reveals distinct patterns of interferon response after Covid-19 mRNA vaccination and SARS-CoV2 infection

D. Chaussabel, A. Ballestrero, D. Bedognetti, 2021, bioRxiv.

Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era

D. Bedognetti, M. Ferrarini, F. Boccardo, 2010, International journal of hematology.

Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol

K. Schughart, D. Chaussabel, A. Ballestrero, 2021, BMJ Open.

The perception of nanotechnology and nanomedicine: a worldwide social media study.

Lucia Gemma Delogu, Alberto Bianco, Davide Bedognetti, 2014, Nanomedicine.

Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry

Rosalyn W. Sayaman, E. Ziv, Raghvendra Mall, 2021, npj Breast Cancer.

Identification of erythroid cell positive blood transcriptome phenotypes associated with severe respiratory syncytial virus infection

Darawan Rinchai, Damien Chaussabel, David Klatzmann, 2019, bioRxiv.

Organizing gene literature retrieval, profiling, and visualization training workshops for early career researchers

D. Chaussabel, D. Bedognetti, D. Rinchai, 2021, F1000Research.

Pharmacogenetics driving personalized medicine: analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations

D. Bedognetti, P. Gasparini, M. Cocca, 2016, Journal of Translational Medicine.

SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in ovarian cancer

A. Ballestrero, D. Bedognetti, J. Rodriguez-Canales, 2020, bioRxiv.

An integrated tumor, immune and microbiome atlas of colon cancer

Rosalyn W. Sayaman, Tariq Ahmad Masoodi, F. Marincola, 2023, Nature Medicine.

Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens.

F. Marincola, D. Bedognetti, M. Ferrarini, 2012, Blood.

Gynaecomastia: The Anastrozole Paradox

D. Bedognetti, F. Boccardo, A. Rubagotti, 2010, Journal of pediatric endocrinology & metabolism : JPEM.

Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod

F. Marincola, A. Heguy, S. Demaria, 2019, Scientific Reports.

NGS technology applied to melanoma cell lines

F. Marincola, D. Bedognetti, E. Wang, 2013, Journal of Immunotherapy for Cancer.

Characterizing blood modular transcriptional repertoire perturbations in patients with RSV infection: a hands-on workshop using public datasets as a source of training material

Darawan Rinchai, David Klatzmann, Davide Bedognetti, 2019 .

SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art

Pier Federico Gherardini, Marta Luksza, Bernard A. Fox, 2018, Journal of Immunotherapy for Cancer.

Correction to: Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer

A. Ballestrero, D. Bedognetti, Sylvain Brohée, 2019, Breast Cancer Research and Treatment.

Conservation of immune gene signatures in solid tumors and prognostic implications

L. Miller, D. Bedognetti, J. Chou, 2016, BMC Cancer.

Signatures Associated with Acute Rejection: Allograft Rejection

D. Bedognetti, 2011 .

Monoallelic expression in melanoma

Hakeem G. Almabrazi, F. Marincola, B. Seliger, 2016, Journal of translational medicine.

Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus

F. Marincola, D. Bedognetti, K. Matsuura, 2015, Journal of Translational Medicine.

Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort study.

Najeeb M. Halabi, D. Bedognetti, Khalid Kunji, 2022, The Lancet. Oncology.

Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells

F. Marincola, G. Cesareni, D. Bedognetti, 2017, Nature Communications.

V4C3 MXene Immune Profiling and Modulation of T Cell‐Dendritic Cell Function and Interaction

K. Ley, Y. Gogotsi, D. Bedognetti, 2023, Small methods.

Organizing training workshops on gene literature retrieval, profiling, and visualization for early career researchers

D. Chaussabel, D. Bedognetti, D. Rinchai, 2023, F1000Research.

Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells.

F. Marincola, D. Bedognetti, M. Sabatino, 2009 .

Functionalized carbon nanotubes as immunomodulator systems

C. Bernardini, D. Bedognetti, M. Pescatori, 2013 .

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer

F. Marincola, F. Bertucci, D. Birnbaum, 2018, British Journal of Cancer.

Myeloid cells are enriched in tonsillar crypts providing insight into the host tropism of HPV.

F. Marincola, D. Bedognetti, A. Mattox, 2021, The American journal of pathology.

Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer

Y. Pommier, A. Ballestrero, D. Bedognetti, 2017, Journal of Translational Medicine.

A collection of annotated and harmonized human breast cancer transcriptome datasets, including immunologic classification.

Sabri Boughorbel, Michele Ceccarelli, Scott R. Presnell, 2017, F1000Research.

Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry

Rosalyn W. Sayaman, E. Ziv, Raghvendra Mall, 2021, npj Breast Cancer.

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.

F. Marincola, J. Galon, D. Bedognetti, 2013, Immunity.

The Immune Landscape of Cancer.

James A. Eddy, David L. Gibbs, Christopher A. Miller, 2018, Immunity.

Title: The abundance of Nudix hydrolase 16 transcripts is elevated in human 1 sepsis: perspectives gained during a hands-on reductionist investigation

D. Chaussabel, S. Boughorbel, D. Bedognetti, 2018 .

Bevacizumab plus Fotemustine as First-line Treatment in Metastatic Melanoma Patients: Clinical Activity and Modulation of Angiogenesis and Lymphangiogenesis Factors

D. Bedognetti, P. Queirolo, M. Del Vecchio, 2010, Clinical Cancer Research.

Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients

F. Marincola, D. Bedognetti, M. Maio, 2017, Oncoimmunology.

Evolution of Metastases in Space and Time under Immune Selection

F. Marincola, M. Ceccarelli, J. Galon, 2018, Cell.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.

Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells.

A. Ballestrero, F. Patrone, S. Parodi, 2010, Experimental hematology.

The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28–Costimulated T Cells Prepared for Adoptive Therapy

F. Marincola, G. Coukos, D. Bedognetti, 2015, Clinical Cancer Research.

Impact of carbon nanotubes and graphene on immune cells

F. Marincola, D. Bedognetti, A. Bianco, 2014, Journal of Translational Medicine.

How can nanotechnology help the fight against breast cancer?

D. Bedognetti, A. Bianco, G. Ciofani, 2018, Nanoscale.

BloodGen3Module: blood transcriptional module repertoire analysis and visualization using R

Darawan Rinchai, Damien Chaussabel, Mohammed Toufiq, 2021, Bioinform..

Editorial Board / Contents / Imprint

F. Marincola, A. Schneeweiss, F. Schuetz, 2016, Oncology Research and Treatment.

Development and Characterization of a Fixed Repertoire of Blood Transcriptome Modules Based on Co-expression Patterns Across Immunological States

Scott R. Presnell, Garand, Lertmemongkolchai, 2019, bioRxiv.

Bach2 represses effector programmes to stabilize Treg-mediated immune homeostasis

D. Bedognetti, P. Muranski, G. Punkosdy, 2013, Nature.

Bach2 represses effector programmes to stabilize Treg-mediated immune homeostasis

D. Bedognetti, G. Punkosdy, C. Klebanoff, 2013 .

DIACYLGLYCEROL KINASE z LIMITS IL-2-DEPENDENT CONTROL OF PD-1 EXPRESSION IN TUMOR- INFILTRATING T LYMPHOCYTES

D. Bedognetti, A. Ávila-Flores, J. Leitner, 2020 .

TITLE: A modular framework for the development of targeted Covid-19 blood

Chaussabel, A. Ballestrero, D. Bedognetti, 2020 .